New research into the causes of cervical cancer appears to lend weight to the promise of a potential early detection method that could help prevent human papillomavirus disease.

Because the first national study of its kind has found that U.S. mothers report they are less likely to vaccinate daughters under age 13 against human papillomavirus (HPV), even though the vaccine is recommended for girls at age 11 and 12, it’s incumbent upon the healthcare community to work to improve mom’s acceptance of the vaccination for younger daughters, say researchers at Cincinnati Children’s Hospital Medical Center who conducted the study.

Watchful waiting may be an adequate initial treatment for many women infected with a carcinogenic type of human papillomavirus (HPV) if they have normal cervical cell cytology.

Human papillomavirus (HPV) DNA-based tests are more accurate than cytology (Pap smears) in detecting cervical precancerous lesions, according to data from a randomized controlled trial.

A tattoo can be more than just a fashion statement – it has potential medical value, according to an article published in the online open access journal, Genetic Vaccines and Therapy.

For the first time researchers from Pennsylvania State University College of Medicine suggest a direct interaction between cigarette smoke carcinogens and the human papillomavirus that may lead to increased risk of cervical cancer. They report their findings in the January 2008 issue of the Journal of Virology.

New Brown University research shows that alcohol and tobacco use doesn’t increase the risk of cancers of the mouth and throat for people infected with human papillo-mavirus 16 (HPV16), a common sexually transmitted virus in the U.S. The findings are the strongest evidence yet that head and neck cancers have two distinct causes and may require different prevention and treatment methods.

A new vaccine against nine of the most harmful strains of human papillomavirus is under study at the Medical College of Georgia.

Canadians would welcome a vaccine against the human papillomavirus (HPV) if it were introduced at no charge, a Quebec, Canada survey suggests. Research published in the open access online journal BMC Public Health shows that 91% of young women (18-25 year-olds) would agree to vaccination, and that 89% of men and women would recommend it to their daughters or nieces

A new study led by McGill University researchers shows that the human papillomavirus (HPV) screening test is far more accurate than the traditional Pap test in detecting cervical cancer.

The routine vaccination of children against Human Papilloma Virus (HPV) - the first adolescent vaccine against a sexually transmitted infection - will be discussed at the National Cancer Research Institute conference in Birmingham today (1515hrs, Tuesday 2 October).

The Human Papillomavirus (HPV) is considered the cause of one of the most important sexually transmitted diseases nowadays, and affects both men and women. HPV is so common in our society that only people who have never had sexual relations can be sure that they have not been exposed to this disease.